Virtual Biopsy Market to Reach USD 6.8 Billion by 2030

Introduction
Pune, India - Exactitude Consultancy releases its latest findings on the Virtual Biopsy Market, showcasing how artificial intelligence, 3D imaging, and radiomics-based tissue characterization are revolutionizing the diagnosis of cancers and critical diseases-without the need for tissue extraction. With hospitals and research centers shifting toward non-invasive, faster, and safer diagnostic methods, the virtual biopsy industry is entering a high-growth phase through 2030.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73687

Key Takeaways
• Market Size (2030): USD 6.8 Billion
• CAGR (2025-2030): 19.7%
• MRI-based virtual biopsies hold the largest share due to accuracy in soft-tissue assessment.
• AI and machine-learning-driven radiomics sharply improve prediction accuracy.
• Oncology remains the highest-impact application segment.

Market Story: Why Virtual Biopsies Are Gaining Momentum
Virtual biopsies eliminate the risks of bleeding, infection, and sampling errors associated with traditional tissue biopsies. Instead, clinicians use AI-enhanced imaging modalities to examine microscopic tissue-level patterns, enabling:

• Faster diagnosis
• Real-time disease monitoring
• Non-invasive detection of abnormalities
• Multi-parametric imaging for precision medicine
• Greater accuracy in tumor heterogeneity assessment
As healthcare shifts toward minimally invasive diagnostics, virtual biopsy technologies are becoming central to high-end clinical decision support systems.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/73687/virtual-biopsy-market

Market Segments
By Imaging Modality
• MRI (Largest Share)
• CT
• Ultrasound
• PET
• Others (Photoacoustic Imaging, Optical Imaging)

By Technology
• Radiomics & AI-Based Image Analysis
• Computer Vision
• Machine Learning Classification
• Deep Learning-Based Segmentation
• 3D/4D Reconstruction Technologies

By Application
• Oncology (Leading segment) - Liver, breast, lung, prostate, and brain tumors
• Neurology
• Cardiology
• Gastroenterology
• Orthopedics
• Dermatology
• Chronic Disease Assessment

By End User
• Hospitals
• Diagnostic Imaging Centers
• Research Institutions
• Specialty Clinics
• AI Health-Tech Companies

By Region
• North America - Strongest adoption with advanced imaging infrastructure
• Europe - High investment in AI-driven diagnostics and radiology innovation
• Asia Pacific - Fastest-growing region due to rising cancer incidence & AI adoption
• Latin America - Growing modernization of radiology departments
• Middle East & Africa - Increasing private-sector investments in imaging centers

Recent Developments
• Siemens Healthineers introduced next-generation AI imaging algorithms to support virtual tissue characterization.
• GE HealthCare expanded its MRI radiomics platform for tumor profiling and early-stage cancer analytics.
• Philips deployed cloud-based imaging AI to enhance non-invasive diagnosis for oncology and neurology.
• Canon Medical launched AI-powered reconstruction engines to enable high-fidelity virtual imaging.
• Arterys advanced cloud-native radiomics tools for precision oncology workflows.

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73687

Expert Quote
"Virtual biopsy technology is redefining diagnostic accuracy by combining the power of AI and high-resolution imaging. This non-invasive approach is poised to become a clinical standard for early detection and personalized treatment planning,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy

Key Drivers
• Rising global cancer burden and need for early diagnosis
• Growing preference for non-invasive, patient-friendly diagnostic procedures
• Rapid advancements in AI, deep learning, and radiomics
• Shorter turnaround time compared to conventional biopsies
• Reduced healthcare costs associated with invasive procedures
• Growing research funding for precision medicine

Forecast Outlook (2025-2030)
The market is projected to expand at an impressive 19.7% CAGR, driven by AI-enabled imaging innovations, expanding digital pathology ecosystems, and increased use of radiomics in clinical workflows. Virtual biopsies are expected to become a cornerstone diagnostic tool for oncology and chronic disease management by 2030.

Regional Insights
• North America: Leads due to advanced radiology systems, strong AI adoption, and major imaging OEM presence.
• Europe: High research collaborations and AI-driven clinical trial initiatives.
• Asia Pacific: Fastest-growing region, powered by cancer screening programs and imaging infrastructure expansion.
• MEA & LATAM: Steady rise in digital imaging solutions and private healthcare investments.

Conclusion
The Virtual Biopsy Market is advancing rapidly as hospitals move toward non-invasive, AI-enhanced diagnostic pathways. With increasing precision, faster analysis, and greater patient comfort, virtual biopsies are becoming an essential component of next-generation healthcare diagnostics.

This report is also available in the following languages : Japanese (バーチャル生検市場), Korean (가상 생체검사 시장), Chinese (虚拟活检市场), French (Marché de la biopsie virtuelle), German (Markt für virtuelle Biopsien), and Italian (Mercato della biopsia virtuale), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73687

Our More Reports:

Healthcare Cybersecurity Market
https://exactitudeconsultancy.com/reports/73723/healthcare-cybersecurity-market

NLP in Healthcare and Life Sciences Market
https://exactitudeconsultancy.com/reports/73725/nlp-in-healthcare-and-life-sciences-market

Gallium-Oxide Power Devices Market
https://exactitudeconsultancy.com/reports/73851/gallium-oxide-power-devices-market

Electric Vehicle Traction Motor Market
https://exactitudeconsultancy.com/reports/73853/electric-vehicle-traction-motor-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.